AR089372A1 - Composiciones de cuidado oral - Google Patents

Composiciones de cuidado oral

Info

Publication number
AR089372A1
AR089372A1 ARP120104872A ARP120104872A AR089372A1 AR 089372 A1 AR089372 A1 AR 089372A1 AR P120104872 A ARP120104872 A AR P120104872A AR P120104872 A ARP120104872 A AR P120104872A AR 089372 A1 AR089372 A1 AR 089372A1
Authority
AR
Argentina
Prior art keywords
compound
composition according
formula
quaternary ammonium
composition
Prior art date
Application number
ARP120104872A
Other languages
English (en)
Inventor
Szewczyk Gregory
Hao Zhigang
Vazquez Joe
Chen Dandan
Mahendra Trivedi Harsh
Mehreteab Ammanuel
Du-Thumm Laurence
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of AR089372A1 publication Critical patent/AR089372A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composiciones orales acuosas que contienen un compuesto esteroideo catiónico y un compuesto de amonio cuaternario; así como procedimientos para la formación y la utilización de ellas. Reivindicación 1: Una composición acuosa de cuidado oral caracterizada porque está compuesta por: un compuesto esteroideo catiónico; y un compuesto de amonio cuaternario. Reivindicación 3: La composición de acuerdo con la reivindicación 1 o la reivindicación 2, caracterizada porque el compuesto esteroideo catiónico es un compuesto de la fórmula (1), en la que R¹ se selecciona entre -OH y NH-R²; R² es alquilo C₂₋₁₄, alquenilo C₂₋₁₄ o alquinilo C₂₋₁₄, y n es un número entero 3 ó 4. Reivindicación 4: La composición de acuerdo con la reivindicación 3, caracterizada porque el compuesto de la fórmula (1), se elige de un compuesto de la fórmula (2) y un compuesto de la fórmula (3). Reivindicación 5: La composición de acuerdo con cualquiera de las reivindicaciones precedentes, caracterizada porque el compuesto esteroideo catiónico es un compuesto de la formula (2). Reivindicación 7: La composición de acuerdo con cualquiera de las reivindicaciones precedentes, caracterizada porque el compuesto de amonio cuaternario contiene cloruro de cetilpiridinio. Reivindicación 8: La composición de acuerdo con cualquiera de las reivindicaciones precedentes, caracterizada porque el compuesto esteroideo catiónico está presente en una concentración de aproximadamente 0,01% a aproximadamente 0,1%, en peso, de la composición. Reivindicación 9: La composición de acuerdo con cualquiera de las reivindicaciones precedentes, caracterizada porque el compuesto de amonio cuaternario está presente en una concentración de aproximadamente 0,01% a aproximadamente 0,1%, en peso, de la composición. Reivindicación 14: La composición de acuerdo con la reivindicación 13, caracterizada porque la fuente de ión fluoruro comprende fluoruro de sodio.
ARP120104872A 2011-12-21 2012-12-20 Composiciones de cuidado oral AR089372A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/066482 WO2013109236A2 (en) 2011-12-21 2011-12-21 Oral care compositions

Publications (1)

Publication Number Publication Date
AR089372A1 true AR089372A1 (es) 2014-08-20

Family

ID=48326382

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120104872A AR089372A1 (es) 2011-12-21 2012-12-20 Composiciones de cuidado oral

Country Status (16)

Country Link
US (2) US9345655B2 (es)
EP (2) EP2793832B1 (es)
JP (1) JP6051230B2 (es)
KR (1) KR20140116111A (es)
CN (1) CN104379120A (es)
AR (1) AR089372A1 (es)
AU (1) AU2011385377B2 (es)
BR (1) BR112014015144B1 (es)
CA (1) CA2859325A1 (es)
IL (1) IL233216A0 (es)
MX (1) MX2014007496A (es)
NZ (1) NZ626144A (es)
RU (1) RU2625838C2 (es)
TW (1) TWI559936B (es)
UA (1) UA113298C2 (es)
WO (1) WO2013109236A2 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9943614B2 (en) 2008-06-17 2018-04-17 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
KR102220710B1 (ko) 2011-07-20 2021-03-02 브라이엄 영 유니버시티 소수성 세라게닌 화합물 및 이를 포함하는 기구
US8945217B2 (en) 2011-08-25 2015-02-03 Brigham Young University Medical devices incorporating ceragenin-containing composites
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
CN104080458B (zh) 2011-09-13 2020-06-02 布莱阿姆青年大学 用于组织创伤的愈合的产品
CN104080459B (zh) 2011-09-13 2018-07-03 布莱阿姆青年大学 用于治疗骨疾病和断骨的组合物
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
CN104379120A (zh) 2011-12-21 2015-02-25 布莱阿姆青年大学 口腔护理组合物
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
WO2013165574A2 (en) 2012-05-02 2013-11-07 Brigham Young University Ceragenin particulate materials and methods for making same
BR112015008804A2 (pt) 2012-10-17 2017-07-04 Univ Brigham Young tratamento e prevenção de mastite
US9943529B2 (en) 2013-01-07 2018-04-17 Brigham Young University Methods for reducing cellular proliferation and treating certain diseases
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
WO2014151411A1 (en) 2013-03-15 2014-09-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10441595B2 (en) 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
WO2016172553A1 (en) 2015-04-22 2016-10-27 Savage Paul B Methods for the synthesis of ceragenins
US10370403B2 (en) 2015-04-22 2019-08-06 Brigham Young University Methods for the synthesis of ceragenins
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
KR102809150B1 (ko) 2018-10-12 2025-05-15 주식회사 엘지생활건강 구강 질환의 예방 또는 개선용 구강 위생 조성물
US12186328B2 (en) 2019-05-23 2025-01-07 Brigham Young University Use of CSA compounds to stimulate stem cells and hair growth

Family Cites Families (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1037074B (de) * 1957-03-25 1958-08-21 Schering Ag Mundpflegemittel
US3843779A (en) * 1971-03-22 1974-10-22 Colgate Palmolive Co Process for preparing stable dentifrice
US4289755A (en) * 1980-11-03 1981-09-15 Richardson-Vicks Inc. Stable mouthwash compositions containing zinc and fluoride compounds
US4661341A (en) 1984-10-30 1987-04-28 The Procter & Gamble Company Oral compositions
US5380840A (en) 1985-09-12 1995-01-10 The Upjohn Company Triazinylpiperazinyl steroids
US4842593A (en) 1987-10-09 1989-06-27 The Procter & Gamble Company Disposable absorbent articles for incontinent individuals
US4865855A (en) 1988-01-11 1989-09-12 Kimberly-Clark Corporation Antimicrobial absorbent food pad
US4990338A (en) 1988-05-09 1991-02-05 Dow Corning Corporation Antimicrobial superabsorbent compositions and methods
US5356630A (en) 1989-02-22 1994-10-18 Massachusetts Institute Of Technology Delivery system for controlled release of bioactive factors
US4972848A (en) 1989-08-23 1990-11-27 Medtronic, Inc. Medical electrical lead with polymeric monolithic controlled release device and method of manufacture
US5025754A (en) 1990-02-01 1991-06-25 David Plyler Apparatus and method for providing drinking water to poultry
GB9020075D0 (en) 1990-09-14 1990-10-24 Filler Aaron G Contrast agents for magnetic resonance imaging of axonal transport
US5310545A (en) 1991-04-11 1994-05-10 Drore Eisen Method of treatment using mouthwashes containing steroids and antifungal agents and compositions of matter
US5286479A (en) * 1991-12-10 1994-02-15 The Dow Chemical Company Oral compositions for suppressing mouth odors
JP2877636B2 (ja) 1992-11-18 1999-03-31 積水化成品工業株式会社 抗菌性ドリップシート
US5721359A (en) 1993-03-12 1998-02-24 Pharmacia & Upjohn Company Crystalline ceftiofur free acid
US5407573A (en) 1993-06-01 1995-04-18 Alpine Water Purification, Inc. Continuous flow water-purifying device
JPH09509959A (ja) 1994-03-10 1997-10-07 マガイニン ファーマシューティカルズ インク． ステロイド誘導体、それらを含む薬剤組成物、及びそれらの薬剤学的用途
JP3044367B2 (ja) 1995-11-13 2000-05-22 三洋化成工業株式会社 抗菌性吸水剤組成物およびその製法
US6132765A (en) 1996-04-12 2000-10-17 Uroteq Inc. Drug delivery via therapeutic hydrogels
US5897770A (en) 1997-10-23 1999-04-27 Plymouth Products, Inc. Center core cartridge feeder insert
US6350738B1 (en) 1998-03-06 2002-02-26 Brigham Young University Steroid derived antibiotics
US6767904B2 (en) 1998-03-06 2004-07-27 Bringham Young University Steroid derived antibiotics
CA2322847C (en) 1998-03-06 2008-05-13 Brigham Young University Steroid derived antibiotics
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
NO307168B1 (no) * 1999-03-01 2000-02-21 Orix As Oralt preparat som er effektivt mot halitose
US6673771B1 (en) 1999-07-28 2004-01-06 The Trustees Of The University Of Pennsylvania Methods of inhibiting osteoclast activity
US6551608B2 (en) 2000-03-06 2003-04-22 Porex Technologies Corporation Porous plastic media with antiviral or antimicrobial properties and processes for making the same
WO2002014342A1 (en) 2000-08-15 2002-02-21 Brigham Young University Steroid derived antibiotics
JP3435405B2 (ja) 2000-11-24 2003-08-11 株式会社ティーセル研究所 家畜の乳房炎治療剤及びこれを用いた乳房炎の治療方法
US6514556B2 (en) 2000-12-15 2003-02-04 Ecolab Inc. Method and composition for washing poultry during processing
US6803066B2 (en) 2001-01-18 2004-10-12 Praxair Technology, Inc. Sanitizing food products
JP4674980B2 (ja) * 2001-02-26 2011-04-20 サンスター株式会社 アルコール無配合液体口腔用組成物
EP1372699A4 (en) 2001-02-26 2006-05-24 Univ Sydney METHOD FOR IMPROVING ANIMAL GROWTH PERFORMANCE
ES2189649B1 (es) 2001-06-15 2004-09-16 Oftrai S.L. Nueva composicion desinfectante y antiseptica.
CA2456977C (en) 2001-08-16 2011-06-07 The Trustees Of The University Of Pennsylvania Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
US9056048B2 (en) 2001-08-16 2015-06-16 The Trustees Of The University Of Pennsylvania Synthesis and use of cationic steroids for anti-inflammatory drug therapy
US6939376B2 (en) 2001-11-05 2005-09-06 Sun Biomedical, Ltd. Drug-delivery endovascular stent and method for treating restenosis
DE10218147B4 (de) 2002-04-23 2005-12-22 Stockhausen Gmbh Wasserabsorbierende, die Zersetzung von Körperflüssigkeiten verzögernde Polymerteilchen, deren Herstellung und Verwendung
US6689342B1 (en) * 2002-07-29 2004-02-10 Warner-Lambert Company Oral care compositions comprising tropolone compounds and essential oils and methods of using the same
JP2006503839A (ja) 2002-09-23 2006-02-02 シェーリング　コーポレイション 真菌感染の処置のためのポサコナゾールの使用
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7659061B2 (en) 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
US7282214B2 (en) 2002-12-19 2007-10-16 Johnson & Johnson Vision Care, Inc. Biomedical devices with antimicrobial coatings
PL1608407T3 (pl) 2003-03-20 2006-12-29 Pharmacia Corp Dyspergowana kompozycja środka przeciw-zapalnego
DE10328261B4 (de) 2003-06-23 2007-10-25 Beiersdorf Ag Desinfizierende Auflage mit Silberbeschichtung und ihre Verwendung
EP1638620B2 (en) 2003-06-23 2018-04-25 Beiersdorf AG Antimicrobial wounddressing
US6872303B2 (en) 2003-08-12 2005-03-29 Ian M. Knapp Water treatment cartridge
GB0318901D0 (en) 2003-08-12 2003-09-17 Univ Bath Improvements in or relating to bone substitute material
US20050267051A1 (en) 2003-12-19 2005-12-01 Lee Henry J Antineoplastic and anti-HIV conjugates of steroid acid and nucleosides
US9241885B2 (en) * 2004-01-29 2016-01-26 The Procter & Gamble Company Oral care compositions comprising increased bioavailable levels of quaternary ammonium antimicrobials
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US20060062742A1 (en) 2004-09-21 2006-03-23 The Procter & Gamble Company Compositions for reduction of human malodor
WO2007029773A1 (ja) 2005-09-08 2007-03-15 Kabushiki Kaisha Yakult Honsha コレステロール吸収抑制剤
WO2007089903A2 (en) 2006-02-01 2007-08-09 Brigham Young University Cationic steroid microbial compositions for treating or preventing influenza infections
WO2007089906A2 (en) * 2006-02-01 2007-08-09 Brigham Young University Cationic steroid antimicrobial compositions for treating or preventing herpes infections
EP1978968A2 (en) 2006-02-01 2008-10-15 Brigham Young University Cationic steroid antimicrobial compositions for treating or preventing hiv infections
US7754705B2 (en) 2006-02-01 2010-07-13 Brigham Young University Cationic steroid antimicrobial compositions and methods of use
WO2007134176A2 (en) 2006-05-10 2007-11-22 Microban Products Company Antimicrobial food pad
US7858000B2 (en) 2006-06-08 2010-12-28 Novartis Ag Method of making silicone hydrogel contact lenses
WO2008006083A2 (en) 2006-07-07 2008-01-10 Surmodics, Inc. Beaded wound spacer device
KR100950204B1 (ko) 2006-09-26 2010-03-29 경북대학교 산학협력단 7α-아미노스테로이드 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법 및 이를 유효성분으로함유하는 항암용 또는 항생제 조성물
US7854941B2 (en) 2007-02-12 2010-12-21 The University Of Southern Mississippi Method of attaching drug compounds to non-reactive polymer surfaces
US20090016973A1 (en) 2007-07-09 2009-01-15 Micropure, Inc. Composition and Method for the Prevention of Oral Disease
US8558051B2 (en) 2007-07-18 2013-10-15 The Procter & Gamble Company Disposable absorbent article having odor control system
US8772220B2 (en) 2007-08-24 2014-07-08 Sekisui Specialty Chemicals America, Llc Chemical delivery product and process for making the same
US20090068122A1 (en) 2007-09-06 2009-03-12 Shira Pilch Dentifrice Compositions for Treating Xerostomia
WO2009079066A2 (en) 2007-09-26 2009-06-25 Aparna Biosciences Therapeutic and vaccine polyelectrolyte nanoparticle compositions
GB0724278D0 (en) * 2007-12-13 2008-01-30 Syntopix Ltd uses for antimicrobial agents
US9943614B2 (en) 2008-06-17 2018-04-17 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
US20090324517A1 (en) 2008-06-30 2009-12-31 Dan Kline Halitosis treatment
EP2313101A4 (en) 2008-07-09 2014-05-21 Univ Nebraska FUNCTIONAL MICELLES FOR HARD FIBER-RELATED CHEMICAL RELEASE RELEASE
WO2011066260A2 (en) 2009-11-25 2011-06-03 Michael Zasloff Formulations comprising aminosterols
US8557031B1 (en) 2010-01-07 2013-10-15 Sandia Corporation Methods for attaching polymerizable ceragenins to water treatment membranes using amine and amide linkages
EP2542245A4 (en) 2010-03-04 2013-08-14 Univ Pennsylvania ANTIMICROBIAL CATIONIC STEROIDS AND METHOD FOR THEIR USE
US8871716B2 (en) 2010-10-08 2014-10-28 Korea Advanced Institute Of Science And Technology Use of antimicrobial peptides in regeneration of skin cells
EP2635118A1 (en) 2010-11-03 2013-09-11 Brigham Young University Articles incorporating absorbert polymer and ceragenin compound
GB201021937D0 (en) 2010-12-24 2011-02-02 Reckitt & Colman Overseas Skin sanitizer compositions comprising alcohol based emulsion
CN102172356B (zh) 2011-03-03 2013-04-03 山东农业大学 牛磺鹅去氧胆酸在制备防治骨质疏松的药物中的应用
US8810380B2 (en) 2011-07-01 2014-08-19 Gerald F. Leitz Golf scoring management system
KR102220710B1 (ko) 2011-07-20 2021-03-02 브라이엄 영 유니버시티 소수성 세라게닌 화합물 및 이를 포함하는 기구
US8945217B2 (en) 2011-08-25 2015-02-03 Brigham Young University Medical devices incorporating ceragenin-containing composites
WO2013029059A1 (en) 2011-08-25 2013-02-28 Brigham Young University Medical devices incorporating ceragenin-containing composites
WO2013029055A1 (en) 2011-08-25 2013-02-28 Brigham Young University Incorporation of particulate ceragenins in polymers
CN104080458B (zh) 2011-09-13 2020-06-02 布莱阿姆青年大学 用于组织创伤的愈合的产品
CN104379120A (zh) 2011-12-21 2015-02-25 布莱阿姆青年大学 口腔护理组合物
US20130236619A1 (en) 2012-03-01 2013-09-12 Brigham Young University Anti-microbial food processing compositions including ceragenin compounds and methods of use
US20130280391A1 (en) 2012-04-24 2013-10-24 Brigham Young University Anti-microbial wash compositions including ceragenin compounds and methods of use for treating non-meat food products
BR112015008804A2 (pt) 2012-10-17 2017-07-04 Univ Brigham Young tratamento e prevenção de mastite
US9943529B2 (en) 2013-01-07 2018-04-17 Brigham Young University Methods for reducing cellular proliferation and treating certain diseases
WO2014151411A1 (en) 2013-03-15 2014-09-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use

Also Published As

Publication number Publication date
CA2859325A1 (en) 2013-07-25
NZ626144A (en) 2016-05-27
RU2625838C2 (ru) 2017-07-19
WO2013109236A3 (en) 2013-10-10
AU2011385377B2 (en) 2017-06-01
BR112014015144B1 (pt) 2018-03-27
KR20140116111A (ko) 2014-10-01
IL233216A0 (en) 2014-08-31
JP6051230B2 (ja) 2016-12-27
US9345655B2 (en) 2016-05-24
EP3449900A1 (en) 2019-03-06
US20140369941A1 (en) 2014-12-18
EP2793832A2 (en) 2014-10-29
UA113298C2 (xx) 2017-01-10
JP2015502978A (ja) 2015-01-29
TWI559936B (en) 2016-12-01
MX2014007496A (es) 2015-02-17
CN104379120A (zh) 2015-02-25
EP2793832B1 (en) 2018-05-23
TW201332581A (zh) 2013-08-16
BR112014015144A2 (pt) 2017-06-13
RU2014129813A (ru) 2016-02-10
US20160045421A1 (en) 2016-02-18
WO2013109236A2 (en) 2013-07-25
AU2011385377A1 (en) 2014-07-03

Similar Documents

Publication Publication Date Title
AR089372A1 (es) Composiciones de cuidado oral
CY1124882T1 (el) Αναλογα 1,4-διϋποκατεστημενης πυριδαζινης και μεθοδοι για την θεραπευτικη αγωγη καταστασεων συναφων με ανεπαρκεια smn
ES2626555T3 (es) Pyridone amides como moduladores de canales de sodio
AR093792A1 (es) Composiciones que contienen zinc estables al fluoruro
ECSP16005566A (es) Sulfonamidas como moduladores de canales de sodio
IN2012DN05233A (es)
CR20140305A (es) Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de transtornos inflamatorios
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
PE20130217A1 (es) Composiciones farmaceuticas y metodos para su elaboracion
BR112015021983A2 (pt) compostos heterocíclicos e usos dos mesmos
BR112014015402A8 (pt) composição sólida de cuidado pessoal, produto de cuidado pessoal e método de tratar cabelo e/ou pele
BR112015018663A2 (pt) derivados de piridazinona-amidas
BR112015014477A2 (pt) composições para limpeza pessoal contendo aminoácido de zinco/haleto de trimetilglicina
AR108876A1 (es) Formulaciones y composiciones de análogos de hidroximetionina y procesos para preparar las formulaciones
CY1116168T1 (el) Συγκρυσταλλοι και αλατα αναστολεων toy ccr3
EA201690072A1 (ru) Состав, содержащий гиполипидемическое средство
AR081819A1 (es) Derivados de pirimidil-piperidinil-oxipiridinona, composiciones farmaceuticas que los contienen y uso de los mismos para tratar diabetes, dislipemias, obesidad y otras enfermedades
CR20130501A (es) Derivados novedosos de cefalosporinas y composiciones farmacéuticas de estos
PH12015501752A1 (en) Substituted bisphenyl butanoic phosphonic acid derivatives as nep inhibitors
EA201270302A1 (ru) Безводные формы производных пиридина
EA201591280A1 (ru) Полимиксины, композиции, способы получения и способы применения
AR080796A1 (es) Composiciones acuosas que comprenden un acil-isetionato para el cuidado personal.
BR112014004523A2 (pt) composto e composição aromatizante
EA201391524A1 (ru) Производные гликозида и их применение
BR112015027164A2 (pt) novos compostos com tripla atividade de trombólise, antitrombótica e neutralização de radical, e sua síntese, nanoestrutura e uso

Legal Events

Date Code Title Description
FB Suspension of granting procedure